Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2< /em> and SYNGAP1< /em> < /strong> < /h2>

Original research article by G. Carvil   et al. < /em> (2013) . < /p>

Read the article here< /a> . < /p>

The researchers used genetic sequence analysis to study a group of 65 genes known to cause epilepsy. They found that changes in the  CHD2    < /em>gene were related to health and behavior differences like autism spectrum disorder and epilepsy. < /p>